Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
433
-
Total 13F shares, excl. options
-
90.2M
-
Shares change
-
+1.2M
-
Total reported value, excl. options
-
$8.88B
-
Value change
-
+$133M
-
Put/Call ratio
-
0.84
-
Number of buys
-
194
-
Number of sells
-
-189
-
Price
-
$98.47
Significant Holders of RESMED INC - COM (RMD) as of Q1 2018
483 filings reported holding RMD - RESMED INC - COM as of Q1 2018.
RESMED INC - COM (RMD) has 433 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.2M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (14.5M shares), Capital World Investors (11.7M shares), BlackRock Inc. (11.2M shares), FMR LLC (8.09M shares), STATE STREET CORP (5.61M shares), BAILLIE GIFFORD & CO (4.87M shares), GEODE CAPITAL MANAGEMENT, LLC (1.83M shares), Bank of New York Mellon Corp (1.66M shares), NORTHERN TRUST CORP (1.64M shares), and NORGES BANK (1.04M shares).
This table shows the top 433 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.